CASMedChem

THE TOPIC

THE CASMedCHEM strategy

The progressive aging of the world population brings on the undesired consequence of increasing occurrence of senile dementias such as Alzheimer's disease (AD). There is no doubt that potential selective inhibitors of GSK-3beta may represent an effective new therapeutical approach to the treatment of AD.

The generation of 2D and 3D QSAR models together with docking studies to design new GSK-3beta inhibitors

In collaboration with
prof. Yagamare Fall
Department of Organic Chemistry, Vigo University (Spain)